Home › Funds › Daiichi Life Insurance Co., Ltd. › GILD

Daiichi Life Insurance Co., Ltd. position in GILD

GILEAD SCIENCES INC · Health Care

Daiichi Life Insurance Co., Ltd. reported holding 188,388 shares of GILD (GILEAD SCIENCES INC) in its Q3 2026 13F filing — a position valued at US$28.1M, representing 0.66% of its reported portfolio and ranking #28 among its reported holdings. Daiichi Life Insurance Co., Ltd. has disclosed GILD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)188.39K sh
Reported value held$28.08M
Portfolio Weight0.66%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Daiichi Life Insurance Co., Ltd.'s GILD position evolved

Daiichi Life Insurance Co., Ltd. first disclosed a stake in GILD in Q3 2023 at 760,719 shares (US$57.0M). Across 13 filings, Daiichi Life Insurance Co., Ltd. increased the stake 5 time(s), trimmed it 7 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 188,388 shares valued at US$28.1M — an increase of 4,704 shares quarter over quarter.. Notable position changes include a 57% trim in Q4 2023 (shares fell 9% over the following quarter), a 42% increase in Q2 2024 (shares rose 22% over the following quarter), a 55% trim in Q3 2024 (shares rose 11% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 760.72K $57.01M New
Q4 2023 329.28K $26.68M Reduce
Q1 2024 264.62K $19.38M Reduce
Q2 2024 377.02K $25.87M Add
Q3 2024 171.42K $14.37M Reduce
Q4 2024 168.15K $15.53M Reduce
Q1 2025 211.92K $23.75M Add
Q2 2025 188.09K $20.85M Reduce
Q3 2025 204.19K $22.66M Add
Q4 2025 209.15K $25.67M Add
Q1 2026 195.29K $27.22M Reduce
Q2 2026 183.68K $23.21M Reduce
Q3 2026 188.39K $28.08M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GILD and 13F data

GILD (GILEAD SCIENCES INC) is a Health Care company. 34 other funds we track also report a position in GILD — the largest reported positions include Fidelity Management & Research (FMR) (US$8.68B), Invesco Ltd (US$5.76B), Capital World Investors (US$5.36B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GILD

All GILD fund holders →

FAQ

How long has Daiichi Life Insurance Co., Ltd. held GILD?

Daiichi Life Insurance Co., Ltd. has disclosed GILD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Daiichi Life Insurance Co., Ltd.'s current position in GILD?

As of Q3 2026, Daiichi Life Insurance Co., Ltd. holds 188.39K shares of GILD (GILEAD SCIENCES INC), valued at $28.08M, representing 0.66% of its reported portfolio and ranking #28.

Has Daiichi Life Insurance Co., Ltd. been buying or selling GILD?

In the latest 13F filing (Q3 2026), Daiichi Life Insurance Co., Ltd. increased its position in GILD.

Which other funds hold GILD?

Other major institutional holders of GILD include Fidelity Management & Research (FMR), Invesco Ltd, Capital World Investors, among 34 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.